logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Biotechnology
Filter

Biotechnology

Categories

Sectors

Locations

Exchange

Shandong Luoxin Acquires Constipation Drug in $68 Million Agreement

Aug 7, 2018

Life Science

Resverlogix Corp TSX:RVX Pharmaceutical, Biotechnology, 医药,生物科技

Resverlogix Announces Seventh Positive Recommendation From The Data Safety Monitoring Board For Phase 3 Study of Apabetalone

Aug 7, 2018

Life Science

Google Glass may help kids with autism read facial expressions

Aug 3, 2018

Life Science, Technology

Denali Shares Pop After Positive Parkinson’s Trial Data

Aug 3, 2018

Life Science

Impact Therapeutics Closes $30 Million C Round for Cancer Drugs

Aug 3, 2018

Life Science

BeiGene Sets Price for Honk Kong IPO, Rakes in Almost $1 Billion

Aug 2, 2018

Life Science

Chinese, US Scientists Develop Skin Patch Nanoparticle Flu Vaccine

Aug 2, 2018

Life Science

CY Biotech Acquires China Rights to Obesity Treatment from Eisai,台湾创益生技获得卫材药业减肥药大中华地区授权

CY Biotech Acquires China Rights to Obesity Treatment from Eisai

Aug 2, 2018

Life Science

Naturally Splendid Enterprises Ltd TSXV:NSP Biotechnology, Nutraceutical, Consumer Products and Services, 生物科技,营养品,消费品,

Naturally Splendid’s President and Co-Founder Presents Investor Roadshow at Cannabis Online Investment Conference

Aug 2, 2018

Life Science

Clover Biopharmaceuticals Initiates Phase I Study of Etanercept Biosimilar Candidate SCB-808 in China

Aug 1, 2018

Life Science

China’s Ascletis Debuted: Stocks Flat

Aug 1, 2018

Life Science

CMS in $70 Million Deal for French Thrombotic Therapy

Aug 1, 2018

Life Science

China Diagnostics Medical Raises $292 Million led by Legend’s $100 Million

Aug 1, 2018

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Life Sciences Announces Grant of Stock Options

Aug 1, 2018

Life Science

HiFiBiO Therapeutics Signs Multi-Target Antibody Discovery Agreement with Takeda

Jul 31, 2018

Life Science

Curon Biopharma of Shanghai Completes $150 Million Initial Financing

Jul 31, 2018

Life Science

Laekna Acquires Exclusive Worldwide Rights to Two Clinical Stage Oncology Assets

Jul 31, 2018

Life Science

Resverlogix Corp TSX:RVX Pharmaceutical, Biotechnology, 医药,生物科技

Resverlogix Intends to Pursue U.S. Listing

Jul 31, 2018

Life Science

  • ‹‹ Previous
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada